Last reviewed · How we verify
NCT05741112
The Long COVID-19 Wearable Device Study
NA trial testing Wearable device in Long COVID in 100,500 participants. Currently enrolling.
1 December 2025
Quick facts
| Lead sponsor | Scripps Translational Science Institute |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 100,500 |
| Start date | 16 November 2023 |
| Primary completion | 1 December 2025 |
| Estimated completion | 1 December 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Wearable device
Conditions studied
- Long COVID — all drugs for Long COVID →
- Postural Orthostatic Tachycardia Syndrome — all drugs for Postural Orthostatic Tachycardia Syndrome →
- Dysautonomia — all drugs for Dysautonomia →
- Myalgic Encephalomyelitis — all drugs for Myalgic Encephalomyelitis →
Sponsor
Scripps Translational Science Institute
Who can join
18 and older, any sex, with Long COVID or Postural Orthostatic Tachycardia Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To further characterize Long COVID-19 by collecting data from individuals who already own wearable devices or are provided with a wearable device along with basic and enhanced educational materials to determine if both can improve Long COVID-19 symptom management and post-exertional malaise.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): diagnosis and management.
Fan J, Jiao J, Chang HQ, Zhong DL, et al · · 2025 · PMID 41366804 · DOI 10.1186/s12967-025-07506-y
Verify or expand the search:
- PubMed search for NCT05741112
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Wearable device
Trials testing the same drug.
- NCT06887387 — Wearable Devices for Patient Monitoring in Long QT Syndrome · recruiting
- NCT06538155 — Technological and Patient-tailored Innovations for Maximizing Effectiveness of Cardiac Arrest Resuscitation · recruiting
- NCT05173870 — Remote Monitoring to Prevent Frailty Progression in the Elderly · terminated
- NCT04736576 — Study to Evaluate Patient Reported Outcome (PRO) and Physical Activity in Japanese Patients With HR+/HER2- Advanced Brea · NA · completed
- NCT04489186 — Continuous Cardiorespiratory Monitoring in Cystic Fibrosis · NA · completed
Other recruiting trials for Long COVID
Currently open trials in the same condition.
- NCT05931497 — Sauna for Long Covid · NA · recruiting
- NCT06452095 — Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial - Effect of Hyperbaric Oxygen Therapy fo · NA · recruiting
- NCT07316127 — Immunoadsorption in Autoimmune Long COVID · Phase 2 · recruiting
- NCT07435805 — Long-Term Health Effects of Previous COVID-19 in Patients Undergoing Preoperative Anesthesia Evaluation · recruiting
- NCT07278206 — Brain Stimulation in Long COVID · NA · recruiting
Other Scripps Translational Science Institute trials
Trials by the same sponsor.
- NCT06244940 — The Sequencing for Detection in Congenital Heart Disease (SD-CHD) Study · NA · recruiting
- NCT05655546 — ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals · NA · terminated
- NCT05197738 — Research Framework Exploring Sleep Health · recruiting
- NCT04881019 — PRediction Of Glycemic RESponse Study · active not recruiting
- NCT03878537 — Recurrence Monitoring in NSCLC Using Circulating Tumor DNA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05741112 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Scripps Translational Science Institute
- Last refreshed: 11 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05741112.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing